Described herein are antibodies that target Leukemia Inhibitory Factor (LIF). Also described herein are uses of these antibodies for the treatment of cancer.L'invention concerne des anticorps ciblant le facteur inhibiteur de leucémie (LIF). L'invention concerne également l'utilisation desdits anticorps pour le traitement du cancer.